Francois Binette - 22 Jul 2022 Form 3/A Insider Report for RENOVARO BIOSCIENCES INC. (RENB)

Role
COO and Executive VP for R&D
Signature
/s/ Francois Binette
Issuer symbol
RENB
Transactions as of
22 Jul 2022
Net transactions value
$0
Form type
3/A
Filing time
16 Feb 2024, 09:38:57 UTC
Date Of Original Report
18 Aug 2022
Next filing
27 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RENB Option to purchase shares of Common Stock 22 Jul 2022 Common Stock 65,000 $8.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was inadvertently omitted from the reporting person's original Form 3, and from the Form 4 filed by the reporting person after his original Form 3 was filed.